Airway smooth muscle cells, as demonstrated by Carmo-Fernandes et al. (2021), contribute to the progression of lung fibrosis by expressing Wnt5a, which leads to aggravated fibrosis of the lung with poor clinical outcomes. This evidence concerns the gene WNT5A and pulmonary fibrosis.